News
🇺🇸 AmericasLatest pharmaceutical news, drug approvals, and FDA regulatory updates
Latest News
AACR 2024: Oncology News & Key Takeaways - Day 1
AACR 2026 Day 1 featured breakthrough presentations on circulating tumor DNA (ctDNA) as a minimal residual disease biomarker, next-generation antibody-drug conjugates (ADCs), and KRAS-targeted therapies reshaping treatment paradigms across NSCLC, breast, pancreatic, and pediatric cancers.
AACR 2024: Oncology Research Highlights - Day 1 Roundup
AACR 2024 Day 1 sessions explored emerging therapeutic targets, immunotherapy advances, early detection innovations, and combination therapy strategies in oncology research. While specific clinical trial data and drug names from presentations await official conference publication, the meeting underscores the field's continued momentum in precision medicine and cancer treatment optimization.
FDA's REdI Conference 2026: Regulatory Strategies & Insights
The FDA's REdI Annual Conference 2026 will be held on May 19-20, 2026, covering drugs, devices, and biologics. Attendees can learn directly from FDA regulatory experts and participate in Q&A sessions on topics like advanced drug manufacturing and AI in drug development.
ScopeX 2026: Causal AI/ML in Clinical Trials Preview
ScopeX 2026 in Boston will feature PhaseV presenting on Causal AI/ML for clinical trial improvements. The event is anticipated to explore advancements in trial design and execution.
Pharma Manufacturing Innovation: US Events in Early 2026
Several pharma manufacturing events are scheduled for early 2026 in the US, focusing on advanced technologies and regulatory perspectives. ReDI 2026 Conference features FDA presentations on advanced drug manufacturing, clinical trial innovation, and new facility pilot programs.
ISPOR 2026: HEOR Trends in Cardiology - What to Expect
A preview of cardiology-related health economics and outcomes research (HEOR) to be presented at ISPOR 2026, including ATTR-CM research and real-world evidence applications.
BBSW AI Solution 2026: Biotech Innovation Preview
The BBSW AI Solution event will explore the evolving role of AI in transforming pharmaceutical research, drug development, and healthcare delivery. It is expected to provide a platform for networking, knowledge sharing, and potential collaborations.
Bio-IT World 2026: AI in Oncology Takes Center Stage
The Bio-IT World Conference & Expo 2026 will focus on AI applications in life sciences and includes a dedicated AI for Oncology track. The conference will be held in Boston from May 19-21, 2026, in a hybrid format.
ISPOR 2026: HEOR Policy & Pharma Pricing in Focus
A preview of the ISPOR 2026 International Conference, focusing on health economics and outcomes research (HEOR) at the forefront of policy, access, and value. Key topics include pharmaceutical policy, cancer costs, real-world data, and AI applications.
2nd Annual COG 2026: Pharma Insights & Preview
NovaPharmaNews cannot responsibly preview the 2nd Annual COG 2026 without verified event details. Our editorial standards require confirmed agendas, speakers, and pharmaceutical focus before publication—not speculation.
BioMed Israel: What to Expect at the 2026 Biotech Forum
BioMed Israel 2026 is an anticipated biennial biotech forum in Tel Aviv, though official details remain unconfirmed. This preview outlines what US attendees can expect based on historical conference themes and the Israeli biotech innovation landscape.
ASGCT 2026: Calidi Bio's RedTail Platform to Present
Calidi Biotherapeutics (NYSE: CLDI) will present preclinical data on its RedTail platform (CLD-401) at the ASGCT 2026 Annual Meeting, highlighting its systemic virotherapy approach for targeted tumor delivery and immune evasion, supporting a planned IND filing by the end of 2026.
ASGCT 2026: Gene Therapy Advances from Circio, Encoded & More
The ASGCT Annual Meeting 2026 will feature presentations from Circio, Encoded Therapeutics, MiNK Therapeutics, and Calidi Biotherapeutics, highlighting advancements in gene and cell therapies. Key presentations will focus on preclinical and early clinical data updates.
ASGCT 2026: Gene Therapy Manufacturing Advances to Watch
ASGCT 2026, held May 11-15 in Boston, focuses on clinical and biological aspects of gene and cell therapies, with potential manufacturing insights emerging. Companies like Circio, MiNK, and Encoded will present data.
THMA CPE Circle 2026: Pharma Exec Networking Focus
The THMA CPE Circle 2026 offers pharmaceutical executives a valuable opportunity to network with Chief Physician Executives, focusing on physician sponsorship for formulary adoption. The spring event is in Fort Lauderdale, FL, in May, and the fall event is in Scottsdale, AZ, in October.
THMA Oncology Forum 2026: Pharma Insights & Health System Strategy
The THMA Oncology Forum 2026 features Spring (Fort Lauderdale) and Fall (Boston) events, focusing on pharma-health system engagement, pathway governance, and clinical implementation, targeting pharma commercial leaders and oncology market access teams.
APHL 2026 Annual: Public Health Lab Trends in Baltimore
The APHL 2026 Annual Conference will take place May 4–7, 2026, in Baltimore, MD, focusing on public health laboratory trends and best practices. Sessions cover emerging infectious diseases, environmental health, and emergency preparedness.
Excipient World 2026: Trends in Drug Delivery & Formulation
Excipient World Conference & Expo 2026 will highlight the role of pharmaceutical excipients in drug formulation and delivery. Clariant will showcase its functional excipients portfolio.
Pharma Partnering US 2026: Biotech Dealmaking Outlook
Pharma Partnering Summit US 2026 focuses on BD&L deals, R&D collaborations, and M&A. Biotech partnering activity is accelerating, driven by licensing deals and strategic collaborations in oncology, rare diseases, and AI-integrated therapies.
Pharma Partnering US Summit 2026: Biotech Dealmaking Outlook
The Pharma Partnering Summit US 2026, scheduled for April 29–30 in San Diego, focuses on business development and licensing partnerships. The summit features company showcases, expert panels, and extensive networking opportunities.